BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 14514775)

  • 1. Immunohistochemical typing of non-small cell lung cancer on cryostat sections: correlation with clinical parameters and prognosis.
    Hilbe W; Dirnhofer S; Oberwasserlechner F; Eisterer W; Ammann K; Schmid T; Hilbe G; Thaler J; Wöll E
    J Clin Pathol; 2003 Oct; 56(10):736-41. PubMed ID: 14514775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD133 positive endothelial progenitor cells contribute to the tumour vasculature in non-small cell lung cancer.
    Hilbe W; Dirnhofer S; Oberwasserlechner F; Schmid T; Gunsilius E; Hilbe G; Wöll E; Kähler CM
    J Clin Pathol; 2004 Sep; 57(9):965-9. PubMed ID: 15333659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological markers and DNA flow cytometric analysis in radically resected patients with non-small cell lung cancer. A study of the Perugia Multidisciplinary Team for Thoracic Tumors.
    Ludovini V; Pistola L; Gregorc V; Floriani I; Rulli E; Di Carlo L; Semeraro A; Daddi G; Darwish S; Stocchi L; Tofanetti FR; Bellezza G; Sidoni A; Tognellini R; Crinò L; Tonato M
    Tumori; 2008; 94(3):398-405. PubMed ID: 18705409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncogenes and male breast carcinoma: c-erbB-2 and p53 coexpression predicts a poor survival.
    Pich A; Margaria E; Chiusa L
    J Clin Oncol; 2000 Aug; 18(16):2948-56. PubMed ID: 10944127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2.
    Haitel A; Posch B; El-Baz M; Mokhtar AA; Susani M; Ghoneim MA; Marberger M
    J Urol; 2001 May; 165(5):1481-7. PubMed ID: 11342901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological markers in non-small cell lung cancer. Retrospective study of 10 year follow-up after surgery.
    Carbognani P; Tincani G; Crafa P; Sansebastiano G; Pazzini L; Zoni R; Bobbio A; Rusca M
    J Cardiovasc Surg (Torino); 2002 Aug; 43(4):545-8. PubMed ID: 12124571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological prognostic factors for early stage completely resected non-small cell lung cancer.
    Cagini L; Monacelli M; Giustozzi G; Moggi L; Bellezza G; Sidoni A; Bucciarelli E; Darwish S; Ludovini V; Pistola L; Gregorc V; Tonato M
    J Surg Oncol; 2000 May; 74(1):53-60. PubMed ID: 10861611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of p53, MDM2 and c-erb B-2 oncoproteins, epidermal growth factor receptor and proliferation markers in the prognosis of urinary bladder cancer.
    Korkolopoulou P; Christodoulou P; Kapralos P; Exarchakos M; Bisbiroula A; Hadjiyannakis M; Georgountzos C; Thomas-Tsagli E
    Pathol Res Pract; 1997; 193(11-12):767-75. PubMed ID: 9521509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear Y-box binding protein-1, a predictive marker of prognosis, is correlated with expression of HER2/ErbB2 and HER3/ErbB3 in non-small cell lung cancer.
    Kashihara M; Azuma K; Kawahara A; Basaki Y; Hattori S; Yanagawa T; Terazaki Y; Takamori S; Shirouzu K; Aizawa H; Nakano K; Kage M; Kuwano M; Ono M
    J Thorac Oncol; 2009 Sep; 4(9):1066-74. PubMed ID: 19648825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic and diagnostic relevance of hnRNP A2/B1, hnRNP B1 and S100 A2 in non-small cell lung cancer.
    Zech VF; Dlaska M; Tzankov A; Hilbe W
    Cancer Detect Prev; 2006; 30(5):395-402. PubMed ID: 17067748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunocytochemical markers in stage I lung cancer: relevance to prognosis.
    Pastorino U; Andreola S; Tagliabue E; Pezzella F; Incarbone M; Sozzi G; Buyse M; Menard S; Pierotti M; Rilke F
    J Clin Oncol; 1997 Aug; 15(8):2858-65. PubMed ID: 9256129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isoform expression of CD44 adhesion molecules, Bcl-2, p53 and Ki-67 proteins in lung cancer.
    Mizera-Nyczak E; Dyszkiewicz W; Heider KH; Zeromski J
    Tumour Biol; 2001; 22(1):45-53. PubMed ID: 11054026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High predictive value of epidermal growth factor receptor phosphorylation but not of EGFRvIII mutation in resected stage I non-small cell lung cancer (NSCLC).
    Sonnweber B; Dlaska M; Skvortsov S; Dirnhofer S; Schmid T; Hilbe W
    J Clin Pathol; 2006 Mar; 59(3):255-9. PubMed ID: 16505275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In situ distribution of oncogene products and growth factor receptors in breast carcinoma: c-erbB-2 oncoprotein, EGFr, and PDGFr-beta-subunit.
    Kommoss F; Colley M; Hart CE; Franklin WA
    Mol Cell Probes; 1990 Feb; 4(1):11-23. PubMed ID: 1969111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic significance of p53 and bcl-2 expression in lung adenocarcinoma and its correlation with Ki-67 growth fraction.
    Ishida H; Irie K; Itoh T; Furukawa T; Tokunaga O
    Cancer; 1997 Sep; 80(6):1034-45. PubMed ID: 9305703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic role of apoptotic, Bcl-2, c-erbB-2 and p53 tumor markers in salivary gland malignancies.
    Nagler RM; Kerner H; Ben-Eliezer S; Minkov I; Ben-Itzhak O
    Oncology; 2003; 64(4):389-98. PubMed ID: 12759537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Towards a biological staging model for operable non-small cell lung cancer.
    O'Byrne KJ; Cox G; Swinson D; Richardson D; Edwards JG; Lolljee J; Andi A; Koukourakis MI; Giatromanolaki A; Gatter K; Harris AL; Waller D; Jones JL
    Lung Cancer; 2001 Dec; 34 Suppl 2():S83-9. PubMed ID: 11720747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical expression of Bcl-2 protein in breast lesions: correlation with Bax, p53, Rb, C-erbB-2, EGFR and proliferation indices.
    Ioachim EE; Malamou-Mitsi V; Kamina SA; Goussia AC; Agnantis NJ
    Anticancer Res; 2000; 20(6B):4221-5. PubMed ID: 11205251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression of p53, Ki-67, bcl-2, c-erb-2, estrogen, and progesterone receptors in endometrial cancer].
    Pilka R; Mícková I; Lubuský M; Dusková M; Rícánková M; Kudela M
    Ceska Gynekol; 2008 Jul; 73(4):222-7. PubMed ID: 18711961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KAI1/CD82 expression in nonsmall cell lung carcinoma is a novel, favorable prognostic factor: an immunohistochemical analysis.
    Higashiyama M; Kodama K; Yokouchi H; Takami K; Adachi M; Taki T; Ishiguro S; Nakamori S; Yoshie O; Miyake M
    Cancer; 1998 Aug; 83(3):466-74. PubMed ID: 9690539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.